Uncommon Amino Acids and Acid/Base Behaviour of Amino Acids

Introduction

Amino acids are the fundamental building blocks of proteins. While 20 standard amino acids are commonly encoded by the genetic code, several uncommon amino acids exist with specialized, often essential, functions. Additionally, amino acids exhibit unique acid/base behavior due to their amino and carboxyl groups, making them central to enzyme catalysis, protein folding, and physiological buffering. Understanding these concepts is critical for biochemistry, molecular medicine, and protein engineering.

Part 1: Uncommon Amino Acids

Definition and Origin

Uncommon (non-proteinogenic) amino acids are not directly encoded by the DNA template. They arise through:

• Post-translational modifications (PTMs): Enzymatic modification after protein synthesis.

• Metabolic intermediates: Occurring in pathways such as the urea cycle.

• Specialized organisms: Found in archaea, bacteria, or toxins.

Detailed Examples with Functions and Mechanisms

Mechanisms of Formation (Post-Translational Modifications)

• Prolyl hydroxylase: Requires Fe²⁺, O₂, ascorbate (vitamin C). Converts Pro → Hyp in the ER.

• Lysyl hydroxylase: Similar cofactors. Hydroxylysine then glycosylated by galactosyltransferase.

• γ-Glutamyl carboxylase: Vitamin K-dependent; adds CO₂ to glutamate in the ER.

• Peptidylarginine deiminase (PAD): Converts Arg → citrulline (deimination) in histones during NETosis and gene regulation.

• Selenocysteine synthesis: Occurs on its own tRNAˢᵉʳˢᵉᶜ via a multi-step pathway involving selenophosphate and O-phosphoseryl-tRNAᵀʳᵏ kinase.

Biological Importance (Expanded)

Structural Stability:

• Hydroxyproline enables the collagen triple helix to have a half-life of years in bone; without it, denaturation temperature drops from 39°C to <30°C.

Enzyme Catalysis:

• Selenocysteine in glutathione peroxidase (GPx) reduces H₂O₂ and lipid peroxides, protecting membranes. GPx activity is 100–1000× higher than cysteine homologs.

• Thiol/disulfide exchange in thioredoxin reductase uses Sec for efficient electron transfer.

Metabolic Regulation:

• Homocysteine levels (normal 5–15 μM) increase in B12/folate deficiency; each 5 μM rise increases cardiovascular risk by ~60%.

• Ornithine decarboxylase produces putrescine, first step in polyamine synthesis (cell growth).

Blood Clotting & Bone:

• Gla domains of factor II (prothrombin) bind Ca²⁺ and phospholipid membranes, accelerating activation 10,000×.

• Osteocalcin (bone Gla protein) regulates mineralization; undercarboxylated osteocalcin is a biomarker for vitamin K status and fracture risk.

Part 2: Acid/Base Behavior of Amino Acids

Key Concepts with Quantitative Detail

Functional Groups:

• α-Carboxyl (–COOH): pKa ~1.8–2.5 (exact value depends on side chain and environment)

• α-Amino (–NH₃⁺): pKa ~8.8–10.8

• Side chain groups: variable as shown below

Ionization States (for a neutral amino acid like alanine or glycine):

Zwitterion Details:

• At physiological pH (~7.4), free amino acids exist as dipolar ions.

• The zwitterion is a buffer – it resists pH changes near its pKa values.

• Water solubility is high due to charge separation.

pKa Values of Standard Amino Acids (Complete Table)

Calculating Isoelectric Point (pI)

Rules:

• Neutral amino acids (no ionizable side chain): pI = (pKa₁ + pKa₂)/2
  Example: Alanine → (2.34 + 9.69)/2 = 6.01

• Acidic amino acids (Asp, Glu): pI = (pKa₁ + pKa₂ side chain)/2
  Example: Asp → (2.10 + 3.86)/2 = 2.98

• Basic amino acids (Lys, Arg, His): pI = (pKa₂ + pKa₃ side chain)/2
  Example: Lys → (8.95 + 10.53)/2 = 9.74

Practical significance:

• At pI, solubility is minimal (used for protein precipitation in isoelectric focusing).

• Electrophoresis separates proteins by pI (2D-PAGE first dimension).

Buffering Capacity

• Henderson-Hasselbalch equation: pH = pKa + log([A⁻]/[HA])

• Maximum buffering occurs within ±1 pH unit of pKa.

• Histidine (pKa ~6.0) is the only common amino acid that buffers near physiological pH – critical in hemoglobin (Bohr effect: H⁺ binding to His146β stabilizes deoxyhemoglobin, enhancing O₂ release).

• Free amino acids in blood contribute ~10% of plasma buffering; plasma proteins (albumin, globulins) and bicarbonate handle the rest.

Detailed Examples of Acid/Base Behavior

Histidine in Enzyme Active Sites:

• Imidazole pKa = 6.0, allowing protonation/deprotonation at physiological pH.

• In serine proteases (chymotrypsin, trypsin), His57 acts as a general base, abstracting proton from Ser195 to generate a nucleophilic alkoxide.

• In ribonuclease A, His12 and His119 act as acid/base catalysts in RNA cleavage (one donates H⁺, one accepts H⁺).

• In hemoglobin, His146β (pKa ~7.1 in deoxy state, ~6.3 in oxy state) binds H⁺ when O₂ is released, facilitating CO₂ transport (via bicarbonate).

Cysteine Redox Chemistry:

• Thiol (pKa ~8.3) is mostly protonated at pH 7.4, but a small fraction of thiolate (S⁻) is present.

• Thiolate is highly nucleophilic and forms disulfide bonds (R-S-S-R) upon oxidation.

• Redox regulation: Protein tyrosine phosphatases (PTPs) require catalytic Cys thiolate; oxidation inactivates them, regulating signaling.

• Glutathione (GSH): γ-Glu-Cys-Gly, with Cys pKa ~8.7, serves as the major cellular redox buffer ([GSH] = 1–10 mM).

Aspartic & Glutamic Acids in Catalysis:

• Aspartyl proteases (HIV-1 protease, renin, pepsin): Two Asp residues function as acid/base pair at low pH (optimal activity at pH ~3–5). One Asp is protonated, one is deprotonated.

• Enolase: Glu211 abstracts a proton from the substrate (2-phosphoglycerate) during catalysis.

Lysine & Arginine in DNA Binding:

• At pH 7.4, Lys (pKa ~10.5) is fully protonated (+), Arg (pKa ~12.5) is protonated (+).

• These positive charges interact electrostatically with DNA phosphate backbone (negative).

• Histone tails rich in Lys and Arg enable DNA packaging into nucleosomes.

• Acetylation of Lys ε-NH₃⁺ (neutralizes charge) loosens DNA-histone binding, activating transcription.

Biological Importance (Expanded)

Protein Folding and Stability:

• Salt bridges (Asp/Glu⁻ – Lys/Arg⁺) stabilize tertiary structure. A single buried charge can contribute −5 to −10 kcal/mol stabilization energy.

• pH changes can denature proteins by altering ionization states → loss of salt bridges, disruption of H-bonds (e.g., histidine protonation in pH-sensitive proteins).

Enzyme Catalysis:

• Catalytic triads (Ser-His-Asp in serine proteases) rely on precise pKa matching. The Asp lowers His pKa to ~7, making His a stronger base.

• pH optimum of most enzymes is narrow (often ±0.5 pH units). Pepsin (optimum pH ~2, stomach), trypsin (optimum pH ~8, small intestine).

Metabolism:

• Amino acids serve as carbon/nitrogen donors. Example: Alanine → pyruvate (gluconeogenesis); Glutamate → α-ketoglutarate (TCA cycle).

• γ-Aminobutyric acid (GABA): Derived from glutamate by glutamate decarboxylase (requires pyridoxal phosphate). GABA is the main inhibitory neurotransmitter in the CNS.

Physiological Buffering:

• Blood pH maintenance (7.35–7.45): Proteins (hemoglobin, albumin) contribute 15–20% of total buffering. The bicarbonate system (H₂CO₃/HCO₃⁻, pKa 6.1) is primary.

• Respiratory acidosis/alkalosis: Altered CO₂ excretion shifts blood pH; proteins help resist change.

• Metabolic acidosis (diabetic ketoacidosis, lactic acidosis): Plasma proteins buffer excess H⁺; chronic acidosis increases protein catabolism.

Medical and Industrial Applications (Expanded)

Collagen Disorders:

• Scurvy (vitamin C deficiency): Inactive prolyl hydroxylase → unstable collagen → bleeding gums, poor wound healing, petechiae. Treatment: ascorbic acid.

• Osteogenesis imperfecta ("brittle bone disease"): Mutations in collagen type I genes (COL1A1/COL1A2) or hydroxylase defects → fragile bones, blue sclerae.

• Ehlers-Danlos syndromes: Defects in collagen processing or structure (including lysyl hydroxylase deficiency in kyphoscoliotic type).

Blood Clotting & Vitamin K:

• Warfarin (Coumadin): Vitamin K antagonist → undercarboxylated factors II, VII, IX, X → anticoagulation. Monitored by INR (international normalized ratio).

• Vitamin K deficiency bleeding (VKDB) in newborns: Prophylactic vitamin K injection given at birth.

• Use of Gla proteins in diagnostics: PIVKA-II (protein induced by vitamin K absence/antagonist-II) is a biomarker for hepatocellular carcinoma.

Drug Design Targeting Ionization:

• Aspirin (acetylsalicylic acid, pKa ~3.5): Uncharged in stomach (low pH) → absorbed across gastric mucosa. Once in blood (pH 7.4), ionized → trapped in plasma.

• Local anesthetics (lidocaine, pKa ~7.9): Uncharged form crosses nerve membrane; charged form binds Na⁺ channel from inside.

• Proton pump inhibitors (omeprazole, pKa ~4): Weak bases that accumulate in acidic parietal cell canaliculi (pH <2) → activate to sulfenamide → bind H⁺/K⁺ ATPase.

Biotechnology:

• Genetic code expansion: Incorporation of selenocysteine and pyrrolysine (and non-natural analogs like p-azidophenylalanine) into recombinant proteins using orthogonal tRNA/synthetase pairs.

• PET imaging: [¹⁸F]-labeled amino acids (e.g., [¹⁸F]FDOPA for Parkinson's; [¹⁸F]FET for brain tumors) exploit amino acid transport (LAT1) for imaging.

• Biologics manufacturing: Controlling pH during fermentation and purification maintains protein stability and activity.

Advanced Insights

Synthetic Biology:

• Selenoproteins produced in E. coli by recoding UGA stop codon (selenocysteine insertion sequence, SECIS element).

• Non-canonical amino acids (ncAAs) with azide, alkyne, or ketone groups enable site-specific chemical conjugation (e.g., antibody-drug conjugates, ADCs).

• In vivo incorporation of ncAAs for probing protein function (photo-crosslinkers, fluorescent reporters).

Proteomics & Post-Translational Modifications (PTMs):

• Mass spectrometry-based PTM mapping: Hydroxyproline, hydroxylysine, citrulline, γ-carboxyglutamate, and phosphorylation all alter peptide mass.

• Citrullination (deimination): Detected by loss of +0.98 Da (Arg→citrulline). Anti-CCP (cyclic citrullinated peptide) antibodies are diagnostic for rheumatoid arthritis (sensitivity ~80%, specificity ~98%).

• Homocysteinylation: Excess homocysteine forms adducts on lysine residues, damaging proteins (linked to vascular disease).

Pharmacology & Therapeutics:

• Selenomethionine as an antioxidant supplement (controversial efficacy). Excessive selenium is toxic (selenosis → hair loss, nail brittleness, garlic breath).

• β-Methylamino-L-alanine (BMAA): Uncommon amino acid from cyanobacteria; linked to ALS/Parkinsonism-dementia complex (Guam).

• D-Cycloserine (D-Ala analog): Antibiotic inhibiting bacterial cell wall synthesis (alanine racemase inhibitor).

• L-Canavanine (Arg analog): Antimetabolite from jack beans; incorporated into proteins by insects, leading to toxic misfolding.

pH and Disease:

• Tumor acidosis (pH 6.5–7.0): Alters protein function, promotes invasion, and suppresses immune cells (acidosis-induced T cell dysfunction).

• Lysosomal storage diseases (e.g., Gaucher, Niemann-Pick): Altered pH in lysosomes (normally 4.5–5.0) impairs acid hydrolases → substrate accumulation.

• Ischemic stroke: Tissue acidosis (lactic acid) from anaerobic glycolysis exacerbates excitotoxicity and neuronal death.

Key Takeaways 

• Uncommon amino acids (hydroxyproline, selenocysteine, γ-carboxyglutamate, etc.) arise from post-translational modifications or specialized metabolism. They are essential for collagen stability, redox catalysis, blood clotting, and many other functions.

• Deficiencies or mutations affecting these modifications cause scurvy, osteogenesis imperfecta, bleeding disorders, and hyperhomocysteinemia.

• Acid/base behavior of amino acids (zwitterions, pKa values, isoelectric point) determines their charge, solubility, and reactivity.

• Buffering by histidine, side chains, and whole proteins maintains blood pH and facilitates enzyme catalysis.

• pKa shifts in active sites (due to local environment, hydrogen bonding, electrostatic effects) enable catalysis at physiological pH.

• Clinical applications include warfarin (vitamin K antagonist), aspirin absorption, local anesthetics, and isoelectric focusing for protein analysis.

• Advanced tools (genetic code expansion, mass spectrometry, PET tracers) exploit amino acid chemistry for biotechnology and medicine.

Conclusion

Uncommon amino acids dramatically expand the functional repertoire of proteins beyond the genetic code, enabling collagen stability, redox regulation, and blood coagulation. Meanwhile, the acid/base chemistry of all amino acids – defined by precise pKa values and zwitterion formation – governs protein folding, enzyme catalysis, and physiological buffering. Together, these concepts are foundational for understanding normal biochemistry and for developing diagnostics, therapeutics, and engineered proteins. Mastery of amino acid ionization and post-translational diversity is essential for students of biochemistry, molecular medicine, and protein engineering.